ArticleLeukemia2020

Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19.

Mukta Asnani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.